<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26721" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Patau Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Williams</surname>
            <given-names>Grant M.</given-names>
          </name>
          <aff>Keesler AFB</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brady</surname>
            <given-names>Robert</given-names>
          </name>
          <aff>Uniformed Services University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Grant Williams declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Brady declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26721.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Patau syndrome, also called trisomy 13, is a clinical syndrome that occurs when all or some cells of the body contain an extra copy of chromosome 13. It is characterized by cleft lip, cleft palate, cerebral defects, anophthalmia, simian creases, polydactyly, trigger thumbs, and capillary hemangiomata. This activity describes the evaluation and management of Patau syndrome and reviews the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the epidemiology of Patau syndrome.</p></list-item><list-item><p>Describe the use of chorionic villus sampling, amniocentesis, and fetal free DNA analysis in the prenatal evaluation of Patau syndrome.</p></list-item><list-item><p>Review the treatment considerations for patients with Patau syndrome.</p></list-item><list-item><p>Outline the importance of improving care coordination among the interprofessional team to enhance the delivery of care by counseling the family on the poor prognosis of Patau syndrome so they can make informed decisions about its management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26721&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26721">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26721.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Trisomy 13 was first described as the cause of a distinct clinical syndrome in 1960 by Dr. Patau et al.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> The clinical syndrome was initially&#x000a0;characterized as "cerebral defects, apparent anophthalmia, cleft palate, hare lip, simian creases, trigger thumbs, polydactyly, and capillary hemangiomata."<xref ref-type="bibr" rid="article-26721.r2">[2]</xref></p>
        <p>Patau syndrome&#x000a0;is diagnosed either prenatally or at birth.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> Advanced maternal age is a risk for trisomy 13 due to an increased frequency of&#x000a0;nondisjunction.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> However, 20% of Patau syndrome can result from an unbalanced translocation and rarely by mosaicism.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref><xref ref-type="bibr" rid="article-26721.r3">[3]</xref> Multiple large studies have detailed the poor prognosis of patients with Patau syndrome. Median survival is 7 to 10 days in live-born patients, and 90% live for less than 1 year.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref><xref ref-type="bibr" rid="article-26721.r4">[4]</xref> Recently, there have been reports of several cases of longer survival due to aggressive medical therapy.<xref ref-type="bibr" rid="article-26721.r4">[4]</xref> Long surviving patients with Patau syndrome are less likely to have cerebral and cardiovascular malformations, typically the primary cause of the poor prognosis with Patau syndrome.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref><xref ref-type="bibr" rid="article-26721.r4">[4]</xref> Even in these cases of increased survival, severe disability remains the expectation of these patients.<xref ref-type="bibr" rid="article-26721.r4">[4]</xref></p>
      </sec>
      <sec id="article-26721.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The cause of Patau syndrome is the presence of three copies of chromosome 13; this is due most commonly to nondisjunction in meiosis, occurring more frequently in mothers of advanced age (age greater than 35).<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> Another cause is an unbalanced&#x000a0;Robertsonian translocation, which results in two normal copies of chromosome 13 and an additional long arm of chromosome 13.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> Another less common cause is mosaicism, which results in 3 copies of chromosome 13 in some cells and two copies in the others. Mosaicism is the outcome of a mitotic nondisjunction error and is unrelated to maternal age.<xref ref-type="bibr" rid="article-26721.r3">[3]</xref> Prognosis is better in patients with mosaicism and patients with unbalanced translocations.<xref ref-type="bibr" rid="article-26721.r4">[4]</xref></p>
      </sec>
      <sec id="article-26721.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cytogenetic abnormalities are present in 50% of fetal deaths before 20 weeks gestational age and are present in 6% to 13% of stillbirths. Overall, fetal death occurs in 15% of pregnancies that&#x000a0;are recognized&#x000a0;clinically. Trisomy 13 is one of the more common trisomies and occurs in 1 per 5000 total births.<xref ref-type="bibr" rid="article-26721.r5">[5]</xref> This frequency is less common than Down syndrome, which occurs in 1 per 700 total births. The incidence of Edwards syndrome is similar, occurring in about 1 per 5000 live births.</p>
      </sec>
      <sec id="article-26721.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>An extra copy of chromosome 13 causes the defects in Patau syndrome. Advanced maternal age is a risk factor for this pathology because of the increased frequency of&#x000a0;nondisjunction in meiosis.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> This extra copy of chromosome 13 disrupts normal embryonic development and leads to multiple defects.</p>
      </sec>
      <sec id="article-26721.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Infants with Patau syndrome typically have intrauterine growth restriction and microcephaly. Facial defects are primarily midline and include cyclopia, cleft lip, and cleft palate. Facial features include a&#x000a0;sloping forehead, small malformed ears, anophthalmia or microphthalmia, micrognathia, and pre-auricular tags. Central nervous system abnormalities are also usually midline, with alobar&#x000a0;holoprosencephaly being the most common defect. Common extremity defects include postaxial polydactyly, congenital talipes equinovarus, or rocker-bottom feet.<xref ref-type="bibr" rid="article-26721.r3">[3]</xref><xref ref-type="bibr" rid="article-26721.r6">[6]</xref></p>
        <p>The spectrum of cardiac disease in Patau syndrome includes a ventricular septal defect, atrial septal defect, tetralogy of Fallot, atrioventricular septal defect, and double outlet right ventricle. Interestingly, the cardiac defects alone typically are non-lethal in infancy or childhood, even if left untreated.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref></p>
        <p>Additional organ systems affected by abnormalities include the lungs, liver, kidneys, genitourinary tract, digestive tract, and pancreas.<xref ref-type="bibr" rid="article-26721.r6">[6]</xref> Defects in these organ systems that occur&#x000a0;in greater than 50% of patients with Patau syndrome include cryptorchidism, hypospadias, labia minora hypoplasia, and bicornuate&#x000a0;uterus. Abnormalities in these organ systems occurring in less than 50% of patients with Patau syndrome include omphalocele, incomplete rotation of the colon, Meckel diverticulum, polycystic kidney, hydronephrosis, and horseshoe kidney.<xref ref-type="bibr" rid="article-26721.r3">[3]</xref></p>
        <p>Patients surviving past infancy have a severe psychomotor disorder, failure to thrive, intellectual disability, and seizures.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
      </sec>
      <sec id="article-26721.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis of Patau syndrome&#x000a0;can&#x000a0;be made prenatally with&#x000a0;chorionic villi sampling, amniocentesis, or&#x000a0;fetal free DNA analysis.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> These methods of testing detect trisomy 13.&#x000a0;Prenatal ultrasound can also help detect the malformations of Patau syndrome, such as holoprosencephaly or other central nervous system anomalies, facial anomalies, skeletal abnormalities,&#x000a0;renal or cardiac defects, and growth restriction that are typically present.<xref ref-type="bibr" rid="article-26721.r8">[8]</xref><xref ref-type="bibr" rid="article-26721.r9">[9]</xref> Prenatal ultrasound after 17 weeks gestation is most sensitive in detecting the abnormalities of Patau syndrome.<xref ref-type="bibr" rid="article-26721.r9">[9]</xref> Abnormal findings should have confirmation performed with a cytogenetic evaluation of fetal cells.</p>
        <p>Tissue microarray has&#x000a0;increased&#x000a0;the ability to diagnose genetic alterations in fetal death, especially when the fetus is macerated.<xref ref-type="bibr" rid="article-26721.r10">[10]</xref></p>
      </sec>
      <sec id="article-26721.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Intensive treatment of Patau syndrome is controversial due to the universally poor prognosis of patients despite treatment.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
        <p>At delivery, infants diagnosed with Patau syndrome may need post-delivery oxygenation and ventilation; this may require intubation or tracheostomy due to facial defects. Patients with cardiac defects may require cardiac surgery to repair common cardiac abnormalities. Other surgeries may be indicated for common defects including herniorrhaphy, cleft lip repair, feeding tube placement, or corrective orthopedic surgeries.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
        <p>Additional treatments may be performed including specialized dietary feeds, seizure prophylaxis, prophylactic antibiotics for urinary tract infections, and the use of hearing aids.<xref ref-type="bibr" rid="article-26721.r4">[4]</xref></p>
        <p>Despite aggressive management, median survival only extends to 733 days in the most recent cohorts of patients.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
      </sec>
      <sec id="article-26721.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The sonographic findings of a fetus with Patau syndrome may have overlap with Edwards syndrome (trisomy 18), Down syndrome (trisomy 21),&#x000a0;or other chromosomal abnormalities.<xref ref-type="bibr" rid="article-26721.r8">[8]</xref><xref ref-type="bibr" rid="article-26721.r9">[9]</xref> Cytogenetic evaluation with chorionic villi sampling, amniocentesis, fetal free DNA analysis, or tissue microarray would distinguish trisomy 13 from these other cytogenetic abnormalities.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref></p>
      </sec>
      <sec id="article-26721.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Multiple large studies have detailed the overall poor prognosis of patients with Patau syndrome.&#x000a0;Historically, median survival is 7 to 10 days in live-born patients, and 90% do not survive to 1 year.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref><xref ref-type="bibr" rid="article-26721.r4">[4]</xref> Recently, reported cases of longer duration survival have come to light with the use of aggressive medical interventions.<xref ref-type="bibr" rid="article-26721.r4">[4]</xref> Prognosis is better in patients with mosaic Patau syndrome and patients with unbalanced translocations.<xref ref-type="bibr" rid="article-26721.r4">[4]</xref> Aggressive management with surgical and medical intervention may extend median survival to 733 days according to a recent study.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
      </sec>
      <sec id="article-26721.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Ninety percent of patients with Patau syndrome do not survive until one year after birth, and many die in utero.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref> There may be many other complications related to common congenital anomalies if a patient survives past infancy.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
      </sec>
      <sec id="article-26721.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Trisomies and other cytogenetic abnormalities are more common in pregnancies of females of advanced maternal age.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref>&#x000a0;Patients considering getting pregnant at this age should be counseled&#x000a0;on this increased risk. If&#x000a0;a fetus or newborn is diagnosed&#x000a0;with Patau syndrome,&#x000a0;the family should be counseled&#x000a0;on the poor prognosis of the disorder.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
      </sec>
      <sec id="article-26721.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Patau syndrome is caused most commonly by trisomy 13 due to nondisjunction, an unbalanced translocation, or mosaicism.<xref ref-type="bibr" rid="article-26721.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>The prognosis of this disorder is poor, with a median survival of 7 to 10 days without intervention. Aggressive intervention may prolong the median survival, but Patau syndrome typically has a universally poor prognosis.<xref ref-type="bibr" rid="article-26721.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>The distinctive abnormalities for this disorder are midline facial defects, midline CNS defects, heart defects, polydactyly, and failure to thrive.<xref ref-type="bibr" rid="article-26721.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26721.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patau syndrome requires an interprofessional team approach. Parents of patients diagnosed with this devastating disease should be provided with education and support regarding all of the possible complications the infant may be born with. For the delivery, the team would include maternal-fetal medicine specialists, neonatologists, neonatal intensive care nurses, and respiratory therapists. If aggressive medical therapy is to be pursued, otolaryngologists, cardiologists, neurologists, urologists, and orthopedic surgeons would need to collaborate for the best possible outcomes. Physical and occupational therapists may be needed as well as speech therapists and audiologists. As the psychological toll on the families of patients with Patau syndrome is extensive, mental health specialists should be utilized as soon as the diagnosis is made.</p>
      </sec>
      <sec id="article-26721.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26721&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26721">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/patau-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26721">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26721/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26721">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26721.s16">
        <title>References</title>
        <ref id="article-26721.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyllie</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Burn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Natural history of trisomy 13.</article-title>
            <source>Arch Dis Child</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-5</page-range>
            <pub-id pub-id-type="pmid">7979530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>PATAU</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>SMITH</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>THERMAN</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>INHORN</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>WAGNER</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Multiple congenital anomaly caused by an extra autosome.</article-title>
            <source>Lancet</source>
            <year>1960</year>
            <month>Apr</month>
            <day>09</day>
            <volume>1</volume>
            <issue>7128</issue>
            <fpage>790</fpage>
            <page-range>790-3</page-range>
            <pub-id pub-id-type="pmid">14430807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petry</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Polli</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Mattos</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Rosa</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Zen</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Graziadio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Paskulin</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Rosa</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and prognosis of a sample of patients with trisomy 13 (Patau syndrome) from Brazil.</article-title>
            <source>Am J Med Genet A</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>161A</volume>
            <issue>6</issue>
            <fpage>1278</fpage>
            <page-range>1278-83</page-range>
            <pub-id pub-id-type="pmid">23613355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peroos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forsythe</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pugh</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Arthur-Farraj</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hodes</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Longevity and Patau syndrome: what determines survival?</article-title>
            <source>BMJ Case Rep</source>
            <year>2012</year>
            <month>Dec</month>
            <day>06</day>
            <volume>2012</volume>
            <pub-id pub-id-type="pmid">23220825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Springett</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wellesley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Greenlees</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Loane</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Addor</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Arriola</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bergman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cavero-Carbonell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Csaky-Szunyogh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Draper</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Garne</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gatt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haeusler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khoshnood</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klungsoyr</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>McDonnell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nelen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>O'Mahony</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pierini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Queisser-Luft</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rankin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rissmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rounding</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stoianova</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tuckerz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zymak-Zakutnia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011.</article-title>
            <source>Am J Med Genet A</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>167A</volume>
            <issue>12</issue>
            <fpage>3062</fpage>
            <page-range>3062-9</page-range>
            <pub-id pub-id-type="pmid">26347425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Marion</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Trisomies.</article-title>
            <source>Pediatr Rev</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-106</page-range>
            <pub-id pub-id-type="pmid">29437136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsukada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Imataka</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Suzumura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arisaka</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Better prognosis in newborns with trisomy 13 who received intensive treatments: a retrospective study of 16 patients.</article-title>
            <source>Cell Biochem Biophys</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>191</fpage>
            <page-range>191-8</page-range>
            <pub-id pub-id-type="pmid">22487910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehman</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Nyberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Kapur</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Resta</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Luthy</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Trisomy 13 syndrome: prenatal US findings in a review of 33 cases.</article-title>
            <source>Radiology</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>194</volume>
            <issue>1</issue>
            <fpage>217</fpage>
            <page-range>217-22</page-range>
            <pub-id pub-id-type="pmid">7997556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watson</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Wax</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Yamamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Polzin</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Sonographic detection of trisomy 13 in the first and second trimesters of pregnancy.</article-title>
            <source>J Ultrasound Med</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>9</issue>
            <fpage>1209</fpage>
            <page-range>1209-14</page-range>
            <pub-id pub-id-type="pmid">17715315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26721.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>UM</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Saade</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>The role of DNA microarrays in the evaluation of fetal death.</article-title>
            <source>Prenat Diagn</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-5</page-range>
            <pub-id pub-id-type="pmid">22467168</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
